In human breast cancer, CSCs also appear to be enriched within cell subpopulations with a CD44+/CD24-/low surface marker profile or with high intracellular aldehyde dehydrogenase 1 (ALDH1) activity[6-8]. Here, ALDH1A1 is linked to breast carcinoma.